体外受精妊娠中先天性心脏缺陷产前筛查方法的成本效果分析
该决策分析模型从社会视角比较三种筛查策略:解剖超声异常后选择性胎儿超声心动图、仅对卵胞浆内单精子注射(ICSI)后体外受精(IVF)妊娠行胎儿超声心动图、对所有IVF妊娠行胎儿超声心动图。结果显示解剖超声策略成本最低(8119美元)且增量成本效果比远超支付阈值,结论为仅当详细解剖扫描发现心脏异常时行胎儿超声心动图最具成本效果。
要点
- 解剖超声策略成本8119美元,ICSI-only策略8408美元,all IVF策略8560美元。
- ICSI-only相比解剖超声的ICER为每额外QALY 2 840 494美元,远超支付阈值。
- 作者结论:仅当详细解剖扫描发现心脏异常时行胎儿超声心动图最具成本效果。
诊断标准与关键数值
- 解剖超声策略:详细解剖扫描发现心脏异常后选择性行胎儿超声心动图,平均成本8119美元,效果1.74487 QALYs。
- ICSI-only策略:对所有ICSI后IVF妊娠行胎儿超声心动图,平均成本8408美元,效果1.74497 QALYs;相比解剖超声策略的ICER为每额外QALY 2 840 494美元。
- all IVF策略:对所有IVF妊娠行胎儿超声心动图,平均成本8560美元,效果1.74499 QALYs;相比ICSI-only策略的ICER为每额外QALY 5 692 457美元。
- 两个ICER均远超标准支付意愿阈值50 000–100 000美元/QALY。
- ICSI-only相比解剖超声策略每额外检出1例主要先心病的ICER为527 562美元;all IVF相比ICSI-only每检出1例主要先心病的ICER为790 510美元。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine if a policy of universal fetal echocardiography (echo) in pregnancies conceived by in-vitro fertilization (IVF) is cost-effective as a screening strategy for congenital heart defects (CHDs) and to examine the cost-effectiveness of various other CHD screening strategies in IVF pregnancies.
METHODS: A decision-analysis model was designed from a societal perspective with respect to the obstetric patient, to compare the cost-effectiveness of three screening strategies: (1) anatomic ultrasound (US): selective fetal echo following abnormal cardiac findings on detailed anatomic survey; (2) intracytoplasmic sperm injection (ICSI) only: fetal echo for all pregnancies following IVF with ICSI; (3) all IVF: fetal echo for all IVF pregnancies. The model initiated at conception and had a time horizon of 1 year post-delivery. The sensitivities and specificities for each strategy, the probabilities of major and minor CHDs and all other clinical estimates were derived from the literature. Costs, including imaging, consults, surgeries and caregiver productivity losses, were derived from the literature and Medicare databases, and are expressed in USA dollars ($). Effectiveness was quantified as quality-adjusted life years (QALYs), based on how the strategies would affect the quality of life of the obstetric patient. Secondary effectiveness was quantified as number of cases of CHD and, specifically, cases of major CHD, detected.
RESULTS: The average base-case cost of each strategy was as follows: anatomic US, $8119; ICSI only, $8408; and all IVF, $8560. The effectiveness of each strategy was as follows: anatomic US, 1.74487 QALYs; ICSI only, 1.74497 QALYs; and all IVF, 1.74499 QALYs. The ICSI-only strategy had an incremental cost-effectiveness ratio (ICER) of $2 840 494 per additional QALY gained when compared to the anatomic-US strategy, and the all-IVF strategy had an ICER of $5 692 457 per additional QALY when compared with the ICSI-only strategy. Both ICERs exceeded considerably the standard willingness-to-pay threshold of $50 000-$100 000 per QALY. In a secondary analysis, the ICSI-only strategy had an ICER of $527 562 per additional case of major CHD detected when compared to the anatomic-US strategy. All IVF had an ICER of $790 510 per case of major CHD detected when compared with ICSI only. It was determined that it would cost society five times more to detect one additional major CHD through intensive screening of all IVF pregnancies than it would cost to pay for the neonate's first year of care.
CONCLUSION: The most cost-effective method of screening for CHDs in pregnancies following IVF, either with or without ICSI, is to perform a fetal echo only when abnormal cardiac findings are noted on the detailed anatomy scan. Performing routine fetal echo for all IVF pregnancies is not cost-effective. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Chung EH, Lim SL, Havrilesky LJ, et al. Cost-effectiveness of prenatal screening methods for congenital heart defects in pregnancies conceived by in-vitro fertilization. Ultrasound Obstet Gynecol. 2021. PMID: 32304621. doi:10.1002/uog.22048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。